Abstract

One to three percent of live births in the US and Europe are currently brought about with assisted reproductive technologies such as in vitro fertilization (IVF). IVF primarily utilizes fertility hormones, such as LH, FSH and Estrogen to promote ovulation and thus fertility. The effect of estrogen on hepatocellular adenoma (HA) growth is well established through many studies analyzing the relationship between oral contraceptives (OCPs) and hepatocellular adenoma since the 1970s. No current guidelines address IVF and screening or follow up of hepatocellular adenomas. We recommend consider ultrasound screening evaluation and follow up ultrasounds for know hepatocellular adenoma for patients undergoing IVF.